Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px

News > All

Total search results: 16855 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Novartis AG. (10/18/18). "Press Release: Novartis Delivered Strong Growth and Innovation During the Third Quarter, Including Progressing Advanced Therapy Platforms to Drive Future growth". Basel. 2018-10-18
Selexis S.A.. (10/18/18). "Press Release: Selexis and Berkeley Lights Collaborate to Accelerate Cell Line Development with the Beacon Optofluidic Platform". Geneva. 2018-10-18
Acticor Biotech. (10/17/18). "Press Release: Acticor Biotech Raises €15.3M in a Series B Financing". Paris. 2018-10-17
Oncgnostics GmbH. (10/17/18). "Press Release: Cervical Cancer Screening. Oncgnostics Closes further Investment Round". Jena. 2018-10-17
ERS Genomics Ltd.. (10/16/18). "Press Release: ERS Genomics and Syngulon Sign License Agreement on CRISPR/Cas9 Genome Editing Patents for Industrial Applications". Dublin & Seraing. 2018-10-16
MeiraGTx Holdings plc. (10/16/18). "Press Release: MeiraGTx Enters Collaboration with Johnson & Johnson Innovation to Develop Regulatable Gene Therapy Treatment using MeiraGTx Riboswitch Technology". London & New York, NY. 2018-10-16
Genedata AG. (10/16/18). "Press Release: Deep Learning-based Genedata Imagence for Automated High-Content Image Analysis Debuts at SLAS Conference". Basel. 2018-10-16
Sanofi S.A.. (10/16/18). "Press Release: Dupixent (dupilumab) Showed Positive Topline Results in Two Phase 3 trials of Patients with Chronic Rhinosinusitis with Nasal Polyps". Paris & Tarrytown, NY. 2018-10-16
Taiho Ventures, LLC. (10/16/18). "Press Release: Taiho Ventures Expands Investment Pool to US$300 Million to Continue Quality Investments and Accelerate Open Innovation". Menlo Park, CA. 2018-10-16
Immunicum AB. (10/16/18). "Press Release: Immunicum AB (publ) Raises SEK 351M in a Directed Issue and a Fully Guaranteed Rights Issue for Continued Clinical Development of Ilixadencel - a New and Innovative Cancer Immunotherapy [Not for US, AU, CA, et al 2018-10-16
Revolution Medicines, Inc.. (10/16/18). "Press Release: Revolution Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets". Redwood City, CA & Cambridge, MA. 2018-10-16
Quantum Analytics. (10/16/18). "Press Release: New Distribution Agreement with Bruker AXS". Foster City, CA. 2018-10-16
Immunicum AB. (10/16/18). "Press Release: Notice of Extraordinary General Meeting in Immunicum AB (publ)". 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Completes Acquisition of Majority Interest in Infectious Disease Molecular Diagnostics Company Hain Lifescience GmbH". Billerica, MA. 2018-10-16
Randox Laboratories Ltd.. (10/16/18). "Press Release: Randox Collaboration with Centre for Personalised Medicine is Officially Launched". 2018-10-16
Immunicum AB. (10/16/18). "Press Release: Immunicum AB (publ) Clarifies Information Regarding Directed Issue [Not for US, AU, CA, et al.]". 2018-10-16
Arcis Biotechnology Ltd.. (10/16/18). "Press Release: Arcis Biotechnology and Teleflex Sign License Agreement". Daresbury. 2018-10-16
Bruker Corporation. (10/16/18). "Press Release: Bruker Launches the S2 Polar High-Performance, Multi-Element Benchtop EDXRF Analyzer for the Petrochemical Industry". Galveston, TX. 2018-10-16
Amgen Inc.. (10/15/18). "Press Release: Amgen Launches Amgevita (Biosimilar Adalimumab) in Markets across Europe". Thousand Oaks, CA. 2018-10-15
Aimmune Therapeutics, Inc.. (10/15/18). "Press Release: Aimmune Therapeutics Announces Initiation of Phase 2 Study with Regeneron and Sanofi of AR101 with Adjunctive Dupilumab in Peanut-Allergic Patients". Brisbane, CA. 2018-10-15
F-Star Biotechnology Ltd.. (10/15/18). "Press Release: F-star Appoints Dr Eliot Forster as Chief Executive Officer". Cambridge. 2018-10-15
Miltenyi Biotec GmbH. (10/12/18). "Press Release: Miltenyi Biotec Acquires Microscopy Specialist LaVision BioTec". Bergisch Gladbach & Bielefeld. 2018-10-12
Randox Laboratories Ltd.. (10/12/18). "Press Release: Researching the Evidence Investigator". 2018-10-12
Boehringer Ingelheim. (10/12/18). "Press Release: Boehringer Ingelheim Inaugurates Its New Global Centre for Veterinary Vaccine R&D in Lyon, France". Lyon. 2018-10-12
Kiadis Pharma N.V.. (10/12/18). "Press Release: Kiadis Pharma Provides Regulatory and Clinical Update on ATIR101". Amsterdam. 2018-10-12
Curetis N.V.. (10/11/18). "Press Release: Curetis, Beijing Clear Biotech Expand Strategic Collaboration for Unyvero in Greater China". Amsterdam, Holzgerlingen & San Diego, CA. 2018-10-11
Evotec AG. (10/11/18). "Press Release: Evotec and Celgene Expand iPSC Collaboration to Include additional Cell Lines. $6M Payment to Access additional Cell Lines". Hamburg. 2018-10-11
Qiagen N.V.. (10/11/18). "Press Release: Qiagen Launches Novel RNA-seq Library Preparation Solutions for Next-generation Sequencing". Hilden & Germantown, MD. 2018-10-11
Adocia S.A.. (10/11/18). "Press Release: Adocia Informs about a Civil Action Filed by Eli Lilly". Lyon. 2018-10-11
European Commission. (10/11/18). "Press Release: A New Bioeconomy Strategy for a Sustainable Europe. Commission Puts Forward an Action Plan to Develop a Sustainable and Circular Bioeconomy that Serves Europe's Society, Environment and Economy". Brussels. 2018-10-11
Bruker Corporation. (10/11/18). "Press Release: First Global Installation of 9.4 Tesla Preclinical MRI System Combined with PET at The German Cancer Research Center (DKFZ)". Billerica, MA. 2018-10-11
EBD Group. (10/11/18). "Press Release: BIO-Europe 2018 to Bring 4,000 Life Science Leaders to Copenhagen November 5–7". Carlsbad, CA & Copenhagen. 2018-10-11
SmartDyeLivery GmbH. (10/10/18). "Press Release: New Financing Round Secures further Development of Innovative Nanotherapies". Erfurt, München & Jena. 2018-10-10
Avacta Group plc. (10/10/18). "Press Release: Avacta Agrees Affimer Reagent Licensing Deal with New England Biolabs (NEB)". Edinburgh & Glasgow. 2018-10-10
Gotham Therapeutics Corporation. (10/10/18). "Press Release: Gotham Therapeutics Launches with $54 Million Series A". New York, NY. 2018-10-10
Oxford Nanopore Technologies Ltd.. (10/10/18). "Press Release: MinIT Is Out – an Analysis and Device Control Accessory to Enable Powerful, Real-time DNA/RNA Sequencing by Anyone, Anywhere". 2018-10-10
Owlstone Medical. (10/10/18). "Press Release: Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board". Cambridge. 2018-10-10
Forbion Capital Partners. (10/10/18). "Press Release: Forbion Co-leads $54m Series A Financing in Newly Formed Gotham Therapeutics". Naarden & Munich. 2018-10-10
Roslin Cell Therapies (RoslinCT). (10/10/18). "Press Release: RoslinCT and Reprocell Awarded £1.2 Million Project from Innovate UK for Clinical-grade Stem Cell Production". Edinburgh & Glasgow. 2018-10-10
BRAIN AG. (10/10/18). "Press Release: Ludger Roedder to join BRAIN AG Management Board as Chief Business Officer (CBO)". Zwingenberg. 2018-10-10
c-LEcta GmbH. (10/9/18). "Press Release: c-LEcta Accelerates Distribution of Denerase and Signs Sales Agreement with VWR". 2018-10-09
Argen-X N.V. (Argenx). (10/9/18). "Press Release: Argenx Awarded €2.6 Million VLAIO Grant to Explore New Applications of ABDEG Technology". Breda & Ghent. 2018-10-09
MeiraGTx Holdings plc. (10/9/18). "Press Release: MeiraGTx Announces Acquisition of Vector Neurosciences, Gains Phase 2 Gene Therapy Program for Parkinson’s Disease". London & New York. 2018-10-09
Rgenix, Inc.. (10/9/18). "Press Release: Rgenix Raises $40M in Series C Funding To Support Clinical Stage Oncology Programs". New York, NY. 2018-10-09
Nouryon (Starfruit Holdco B.V.). (10/9/18). "Press Release: AkzoNobel Specialty Chemicals is Now Nouryon". 2018-10-09
Hummingbird Diagnostics GmbH. (10/9/18). "Press Release: Jörg Debatin to Chair the Supervisory Board of Hummingbird Diagnostics GmbH". Heidelberg & Boston, MA. 2018-10-09
Euronext N.V.. (10/8/18). "Press Release: Medincell Lists on Euronext Paris. €30 Million Raised, Market Capitalisation €144 Million". Paris. 2018-10-08
Sphingotec GmbH. (10/8/18). "Press Release: Sphingotec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf. 2018-10-08
Epigenomics AG. (10/8/18). "Press Release: Capital Increase through Rights Issue with Subscription Rights of Existing Shareholders [NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAP 2018-10-08
Lipotype GmbH. (10/8/18). "Press Release: Skin Lipidomics in Cosmetics and Dermatology. Lipotype Provides Royal DSM and Lipoid with Shotgun Skin Lipidomics". Dresden. 2018-10-08
Affimed N.V.. (10/8/18). "Press Release: Affimed Places AFM11 (CD19/CD3-Targeting T cell Engager) Phase 1 Program on Clinical Hold". Heidelberg. 2018-10-08
Bluebird Bio, Inc.. (10/5/18). "Press Release: Bluebird Bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin Gene Therapy for the Treatment of Transfusion-Dependent ß-Thalassemia". Cambridge, MA. 2018-10-05
Apceth Biopharma GmbH. (10/5/18). "Press Release: Apceth to Manufacture First Potential One-time Gene Therapy for Transfusion Dependent ß-Thalassemia". Munich. 2018-10-05
Probiodrug AG. (10/5/18). "Press Release: Probiodrug Reports Management Changes". Halle (Saale). 2018-10-05
Evotec AG. (10/4/18). "Press Release: Evotec Signs Agreement with Sanofi to Advance Early Stage Academic Research into Novel Therapeutic Candidates". Hamburg. 2018-10-04
Blackstone. (10/4/18). "Press Release: Blackstone Announces Agreement to Acquire Clarus, a Leading Life Sciences Investment Firm". New York, NY. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: GenAhead Bio and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Celyad S.A.. (10/4/18). "Press Release: Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop NextGeneration Allogeneic CAR-T Therapies". Mont-Saint-Guibert. 2018-10-04
Evotec AG. (10/4/18). "Press Release: LAB150 Awards Its Second Drug Discovery Project from Canada’s Largest Research-based Hospital, The University Health Network (UHN)". Toronto. 2018-10-04
Iqvia. (10/4/18). "Press Release: Iqvia and Genomics England Launch the First Real-World Research Platform with Integrated Clinical and Genomic Data". Danbury, CT & Research Triangle Park, NC. 2018-10-04
ERS Genomics Ltd.. (10/4/18). "Press Release: Axcelead Drug Discovery Partners and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Fujisawa & Dublin. 2018-10-04
Arcis Biotechnology Ltd.. (10/2/18). "Press Release: Arcis Biotechnology Raises £1.25 Million (USD $1.63 Million) Funding and Opens further £0.5 Million Investment Opportunity through Capital Cell". Daresbury. 2018-10-02
Oncgnostics GmbH. (10/2/18). "Press Release: Oncgnostics GmbH Retains Biotech Alliances International Inc. to Support Global Partnering and Distribution Strategy". San Francisco, CA & Jena. 2018-10-02
Curetis N.V.. (10/2/18). "Press Release: Curetis Secures Financing Facility of up to EUR 20 Million through the Issuance of Convertible Notes". Amsterdam, Holzgerlingen & San Diego, CA. 2018-10-02
GO Therapeutics, Inc.. (10/2/18). "Press Release: GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment". Cambridge, MA. 2018-10-02
Novasep S.A.. (10/2/18). "Press Release: Novasep Opens €27m New Viral Vector Commercial Production Facility". Lyon. 2018-10-02
Genedata AG. (10/2/18). "Press Release: Genedata Bioprocess Offers Out-of-the-Box Integration with ambr Bioreactors". Basel. 2018-10-02
MaSTherCell S.A.. (10/1/18). "Press Release: KangStem Biotech Selects MaSTherCell for GMP Manufacturing of Furestem-AD in Europe". Seoul & Gosselies. 2018-10-01
CeGaT GmbH. (10/1/18). "Press Release: Personalized Cancer Therapy. B. Braun and CeGaT Found Joint Venture CeCaVa". Melsungen & Tübingen. 2018-10-01
AiCuris Anti-infective Cures GmbH. (10/1/18). "Press Release: AiCuris to Cooperate with Cyclenium Pharma to Develop Novel Anti-Infectives". Wuppertal & Montreal. 2018-10-01
Forbion Capital Partners. (10/1/18). "Press Release: Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 Million". Naarden & Munich. 2018-10-01
Evonetix Ltd.. (10/1/18). "Press Release: Evonetix Partner with LioniX International to Enable DNA Synthesis at Scale". Cambridge & Enschede. 2018-10-01
Taros Chemicals GmbH & Co. KG. (10/1/18). "Press Release: Taros Appoints Torsten Hoffmann as Senior Vice President Drug Discovery". Dortmund. 2018-10-01
Owlstone Medical Ltd.. (10/1/18). "Press Release: Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round". Cambridge. 2018-10-01
Sanofi S.A.. (10/1/18). "Press Release: Sanofi Completes Divestiture of Zentiva to Advent". Paris. 2018-10-01
Arix Bioscience plc. (10/1/18). "Press Release: Arix Bioscience plc Co-leads $58 Million Series A Investment Round for VelosBio". London. 2018-10-01
Zealand Pharma A/S. (10/1/18). "Press Release: Zealand Pharma Expands Leadership Team and Appoints Marino Garcia as Senior Vice President of Corporate & Business Development". Copenhagen. 2018-10-01
Eurofins Scientific. (10/1/18). "Press Release: Eurofins to Expand Its US Environment Testing Offering with the Acquisition of TestAmerica". 2018-10-01
Sanofi S.A.. (9/28/18). "Press Release: FDA Approves Libtayo (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma". Paris & Tarrytown, NY. 2018-09-28
Vanderbilt University [Hall, Heidi]. (9/28/18). "Press Release: Mass Spectrometry Team Earns Grant to Map Body at the Cellular Level". 2018-09-28
Tusk Therapeutics Ltd.. (9/28/18). "Press Release: Tusk Therapeutics to Be Acquired by Roche". Stevenage. 2018-09-28
Qiagen N.V.. (9/28/18). "Press Release: Qiagen Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer". Germantown, MD & Hilden. 2018-09-28
TTP Labtech Ltd.. (9/27/18). "Press Release: Battery Ventures Acquires TTP Labtech Limited, Global Leader in Liquid Handling & Sample Management Technologies". Cambridge. 2018-09-27
Valneva S.E.. (9/27/18). "Press Release: Valneva Raises €50 Million in Oversubscribed Placement Led by US Healthcare Investors [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-27
Genedata AG. (9/27/18). "Press Release: Bayer Partners with Genedata to Digitalize Crop Science Research and Development". Basel. 2018-09-27
Mologen AG. (9/27/18). "Press Release: Mologen AG Completes Capital Increase with Gross Proceeds of around EUR8 Million [NOT FOR RELEASE IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, et al.]". Berlin. 2018-09-27
Clyde Biosciences Ltd.. (9/27/18). "Press Release: Major International FDA-led Study Confirms CellOptiq High Content Assay as Leading in vitro Platform to Assess Cardiotoxicity in New Drugs". Motherwell. 2018-09-27
Nightstar Therapeutics plc. (9/27/18). "Press Release: Nightstar Announces Pricing of Public Offering". Waltham, MA & London. 2018-09-27
Valneva S.E.. (9/26/18). "Press Release: Valneva Launches a Capital Increase of Approximately €40 Million [Not for Distribution in the United States, Canada, Australia or Japan]". Saint-Herblain. 2018-09-26
Brooks Automation, Inc.. (9/26/18). "Press Release: Brooks Automation Announces the Acquisition of Genewiz Group". Chelmsford, MA. 2018-09-26
Minoryx Therapeutics S.L.. (9/26/18). "Press Release: Minoryx Therapeutics Raises €21.3M in Series B Funding Round". Mataró, Barcelona. 2018-09-26
SGS S.A.. (9/26/18). "Press Release: SGS Issues CHF 225 Million and CHF 175 Million Bonds [NOT FOR DISTRIBUTION IN THE UNITED STATES et al.]". 2018-09-26
Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert. 2018-09-26
BCNP Consultants GmbH. (9/26/18). "Press Release: Over 600 Partnering Discussions at the First European Chemistry Partnering Summer Summit". Düsseldorf. 2018-09-26
Novacyt S.A.. (9/26/18). "Press Release: Novacyt Half Year 2018 Results. Molecular Product Revenues up 18% to €3m – Gross Margin Increases to 64%". Paris & Camberley. 2018-09-26
Nightstar Therapeutics plc. (9/25/18). "Press Release: Nightstar Announces Proposed Public Offering of American Depositary Shares". Waltham, MA & London. 2018-09-25
MaxiVax S.A.. (9/25/18). "Press Release: MaxiVax Starts Phase 2 Study in Switzerland of Innovative Cancer Vaccine in Patients with Head & Neck Cancer". Geneva. 2018-09-25
genOway S.A.. (9/25/18). "Press Release: genOway Announces the Acquisition of Axenis to Create the Largest Offer of Preclinical Models in the Immuno-oncology and Immuno-inflammation Space". Lyon. 2018-09-25
Aktiia S.A.. (9/25/18). "Press Release: Aktiia Closes 4M Seed Round to Reinvent Blood Pressure Monitoring". Neuchâtel. 2018-09-25
Myelo Therapeutics GmbH. (9/25/18). "Press Release: FDA Grants Myelo Therapeutics Orphan Drug Designation for Myelo001 as Treatment for Acute Radiation Syndrome". Berlin. 2018-09-25
next pagenext page 1 2 3 4 ... 167 168 169  next pagenext page



Advertisement

Picture [iito] – Putting Information into Context 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

» top